The random and control study of CapeOX in 70-85 years old patient with radical resection of colorectal carcinoma
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2014
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Planned end date changed from 31 Dec 2012 to 31 Dec 2017 as reported by Chinese Clinical Trial Register.
- 24 Nov 2011 Status changed from recruiting to not yet recruiting as reported by Chinese Clinical Trial Register.
- 11 Oct 2011 New trial record